New Delhi: Alembic Pharmaceuticals said the US health regulator has made three observations after inspecting its formulation facility in Panelav, Guja...
483 observation

Lupin Aurangabad plant undergoes USFDA inspection
New Delhi: Drug major Lupin on Monday said the US health regulator has completed the prior approval inspection (PAI) of its Aurangabad manufacturing p...